Preliminary Experience on the Use of the Adnatest System for Detection of Circulating Tumor Cells in Prostate Cancer Patients
Anticancer Research, 07/27/2012
Todenhofer T et al. – In this preliminary study, the Adnatest detected circulating tumor cells (CTCs) in a considerable proportion of patients with castration–resistant PC. First data on certain markers (EGFR and aldehyd dehydrogenase 1) encourage future studies investigating transcripts predicting treatment response.